CN113616627A - 一种治疗口腔溃疡的双层膜剂及其制备方法 - Google Patents
一种治疗口腔溃疡的双层膜剂及其制备方法 Download PDFInfo
- Publication number
- CN113616627A CN113616627A CN202111117249.7A CN202111117249A CN113616627A CN 113616627 A CN113616627 A CN 113616627A CN 202111117249 A CN202111117249 A CN 202111117249A CN 113616627 A CN113616627 A CN 113616627A
- Authority
- CN
- China
- Prior art keywords
- double
- film
- agent
- drug
- film agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000002399 aphthous stomatitis Diseases 0.000 title claims abstract description 37
- 208000007117 Oral Ulcer Diseases 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 239000003814 drug Substances 0.000 claims abstract description 76
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 55
- 239000012528 membrane Substances 0.000 claims abstract description 46
- 229940079593 drug Drugs 0.000 claims abstract description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000001856 Ethyl cellulose Substances 0.000 claims abstract description 15
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims abstract description 15
- 235000019325 ethyl cellulose Nutrition 0.000 claims abstract description 15
- 229920001249 ethyl cellulose Polymers 0.000 claims abstract description 15
- 229920001661 Chitosan Polymers 0.000 claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 12
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 claims abstract description 9
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 9
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000004372 Polyvinyl alcohol Substances 0.000 claims abstract description 9
- 208000020670 canker sore Diseases 0.000 claims abstract description 9
- 229920001577 copolymer Polymers 0.000 claims abstract description 9
- 229920000639 hydroxypropylmethylcellulose acetate succinate Polymers 0.000 claims abstract description 9
- 229920002451 polyvinyl alcohol Polymers 0.000 claims abstract description 9
- 239000000661 sodium alginate Substances 0.000 claims abstract description 9
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 9
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 9
- 239000000853 adhesive Substances 0.000 claims description 30
- 229920000715 Mucilage Polymers 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 208000025865 Ulcer Diseases 0.000 claims description 11
- 231100000397 ulcer Toxicity 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 8
- 238000003892 spreading Methods 0.000 claims description 8
- 230000007480 spreading Effects 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000000796 flavoring agent Substances 0.000 claims description 6
- 235000013355 food flavoring agent Nutrition 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- 230000001070 adhesive effect Effects 0.000 claims description 5
- 238000001291 vacuum drying Methods 0.000 claims description 5
- 238000005520 cutting process Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 238000000227 grinding Methods 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 4
- 229920000053 polysorbate 80 Polymers 0.000 claims description 4
- 238000007873 sieving Methods 0.000 claims description 4
- 238000007582 slurry-cast process Methods 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000005266 casting Methods 0.000 claims description 3
- 239000004568 cement Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical group OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 claims description 2
- 229940085605 saccharin sodium Drugs 0.000 claims 1
- 230000009471 action Effects 0.000 abstract description 3
- 210000004379 membrane Anatomy 0.000 description 31
- 230000000694 effects Effects 0.000 description 10
- 210000000214 mouth Anatomy 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 4
- 235000020188 drinking water Nutrition 0.000 description 4
- 239000003651 drinking water Substances 0.000 description 4
- 239000004570 mortar (masonry) Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 210000002200 mouth mucosa Anatomy 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000010345 tape casting Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开一种治疗口腔溃疡的双层膜剂及其制备方法。该治疗口腔溃疡的双层膜剂为双层单向释药膜剂，包括多孔的载药内膜和防水外膜；所述载药内膜包括壳聚糖1‑60份，海藻酸钠1‑37份，聚乙烯醇1‑7份；所述防水外膜包括乙基纤维素、甲基丙烯酸羟乙酯、甲基丙烯酸甲酯共聚物、醋酸羟丙甲纤维素琥珀酸酯中的任意一种单独或多种组合经无水乙醇溶解后制成，浓度为1％～5％。本发明解决了OTC(Over The Count)中成药口腔溃疡散使用不方便，药物容易流失，一次用药作用时间短的问题。此外，本发明还提出了该治疗口腔溃疡的双层膜剂的制备方法。
Description
技术领域
本发明涉及医药制备技术领域，特别涉及一种治疗口腔溃疡的双层膜剂及其制备方法。
背景技术
口腔溃疡，又称为“口疮”，是一种十分常见的口腔粘膜疾病。
治疗口腔溃疡的口腔溃疡贴膜，并不是我们想象中的一张透明薄膜，它是一种涂了治疗口腔溃疡药物的一种微小贴膜，可以直接贴在口腔溃疡处，让药物充分运用于口腔溃疡处。根据患者的个人情况，可以选择不同的口腔溃疡贴膜，他们的成分也不尽相同，但是一般都会加入蜂胶和麻药，一来可以减少药物刺激口腔溃疡带来的疼痛，二来可以滋润口腔溃疡周围的口腔黏膜。因此，口腔溃疡贴膜是一种常用来治疗口腔溃疡的方式，如果想要无痛快速治疗口腔溃疡，口腔溃疡贴膜无疑是首选。
现有技术中，北京同仁堂股份有限公司同仁堂制药厂有一种口腔溃疡散的中成药，以青黛清热解毒，凉血疔疮，为主药；辅以冰片凉散清热，消肿止痛；白矾外用解毒杀虫，燥湿止痒，内服止血止泻，祛除风痰。诸药相合，共奏清火敛疮之功效。其用法是用清毒棉球蘸药擦患处，一日2-3次。其缺点是药物使用不方便，药粉涂于患处，药物易被唾液带走，影响药物作用时间，并且药物口感不好。因此，将中成药口腔溃疡散进行剂型改变很有必要。
发明内容
本发明的目的是克服中成药溃疡散使用不方便，药粉涂于患处，药物易被唾液带走，影响药物作用时间，并且药物口感不好的问题，提供了一种治疗口腔溃疡的双层膜剂及其制备方法。
本发明通过现有西药口腔贴膜剂的制备工艺，制备成为双层单向释药膜剂，其包括多孔状的载药内膜和防水外膜，载药内膜包括壳聚糖(CS)，海藻酸钠(ALG)、聚乙烯醇等，其中，壳聚糖(CS)占1-60份，海藻酸钠(ALG)占1-37份，聚乙烯醇占1-7份、矫味剂0.1～1份。载药内膜具有黏附性，能与黏膜紧密接触而不易滑动，其内膜有疏松小孔，有利于药物溶出析出，发挥药效。防水外膜主要包括乙基纤维素、甲基丙烯酸羟乙酯、甲基丙烯酸甲酯共聚物、醋酸羟丙甲纤维素琥珀酸酯中的任意一种或多种组合用无水乙醇溶解，浓度为1％～5％。所述双层膜剂的总厚度为0.3～0.5mm；每片双层膜剂长宽均为1～2cm，每片双层膜剂含药物1～2mg。
本发明中，所述载药内膜的药物是OTC(Over The Count)中成药口腔溃疡散。
本发明的一种治疗口腔溃疡的双层膜剂的制备方法，包括以下步骤：
内膜胶浆的制备：按照壳聚糖1-60份，海藻酸钠1-37份，聚乙烯醇1-7份的比例称取各组分，加水充分溶解，过滤得内膜胶浆；
载药内膜胶浆的制备：将治疗口腔溃疡的药物研细过200目筛，加入内膜胶浆，同时加入丙三醇和吐温80，搅拌充分后静置脱泡，匀浆，得含药内膜胶浆；
防水外膜胶浆的制备：无水乙醇加入高分子防水材料，配成1％～5％的浓度；所述高分子防水材料包括乙基纤维素、甲基丙烯酸羟乙酯、甲基丙烯酸甲酯共聚物、醋酸羟丙甲纤维素琥珀酸酯中的任意一种单独或多种组合；
双层膜剂的制备：按照贴膜剂的生产工艺均浆流延成膜法对载药内膜胶浆进行膜剂的铺膜，真空干燥，小心起膜，干燥后得载药内膜；将载药内膜平铺，量取防水外膜胶浆，再次利用均浆流延成膜法铺于载药内膜上，置于干燥通风阴凉处静置一小时，即得双层的单向释药膜剂，然后进行切割，灭菌，包装，即得治疗口腔溃疡的双层膜剂。制备过程中，载药内膜胶浆和防水外膜胶浆的加入重量比为(10～20)：(80～90)。
真空干燥的条件为50℃、-84kPa保存5小时。
本发明的上述技术方案的有益效果如下：
本发明通过现有西药口腔贴膜剂的制备工艺，将其制成双层单向释药膜剂，载药内膜有疏松小孔，有利于药物溶出析出，发挥药效；外膜不溶于水，起到保护内膜的作用，内膜可保持药物长期与溃疡面接触使疗效增强。贴膜能直接作用到溃疡患处，具有药物缓释效果，能够减轻疼痛、促进伤口愈合、缩短病程，且无副作用，粘附力强，能够牢固且持久的作用于口腔溃疡患处，患者进食和饮水时不易脱落，减少了患者进食或饮水时对口腔溃疡患处的刺激，提高患者使用舒适性。
附图说明
图1为本发明实施例的流程图。
具体实施方式
为使本发明要解决的技术问题、技术方案和优点更加清楚，下面将结合具体实施例进行详细描述。
一种治疗口腔溃疡的双层膜剂的制备方法，包括以下步骤：
内膜胶浆的制备：按照壳聚糖1-60份，海藻酸钠1-37份，聚乙烯醇1-7份，矫味剂0.1～1份的比例称取各组分，加水充分溶解，过滤得内膜胶浆；
载药内膜胶浆的制备：将治疗口腔溃疡的药物研细过200目筛，加入内膜胶浆，同时加入丙三醇和吐温80，搅拌充分后静置脱泡，匀浆，得含药内膜胶浆；
防水外膜胶浆的制备：无水乙醇加入高分子防水材料，配成1％～5％的浓度；所述高分子防水材料包括乙基纤维素、甲基丙烯酸羟乙酯、甲基丙烯酸甲酯共聚物、醋酸羟丙甲纤维素琥珀酸酯中的任意一种单独或多种组合；
双层膜剂的制备：按照贴膜剂的生产工艺均浆流延成膜法对载药内膜胶浆进行膜剂的铺膜，真空干燥，小心起膜，干燥后得载药内膜；将载药内膜平铺，量取防水外膜胶浆，再次利用均浆流延成膜法铺于载药内膜上，置于干燥通风阴凉处静置一小时，即得双层的单向释药膜剂，然后进行切割，灭菌，包装，即得治疗口腔溃疡的双层膜剂。
通过上述方法制备得到的治疗口腔溃疡的双层膜剂为双层单向释药膜剂，包括多孔的载药内膜和防水外膜。
优选实施例
如图1所示的基于口腔溃疡散治疗口腔溃疡的双层膜剂的制备方法，包括以下步骤：
(1)取无水乙醇50mL于研钵中，加入2.500g乙基纤维素，再注入无水乙醇50mL，使乙基纤维素在盛有无水乙醇的研钵中不贴壁并充分溶胀。在研钵中往同一方向匀速研磨30分钟，使乙基纤维素完全溶解，得100mL的2.5％乙基纤维素乙醇溶液。倒入100mL烧杯中，盖上盖子，静置待用；
(2)取口腔溃疡散于研钵，充分研磨后过200目药筛；
(3)量取100mL蒸馏水于250mL的烧杯中，置于恒温磁力搅拌器中10分钟加热到90℃。精密称取聚乙烯醇1.000g，边搅拌边缓慢加入蒸馏水中，搅拌10分钟至溶解完全，再精密称取壳聚糖0.720g，边搅拌边缓慢加入，待壳聚糖分散至在溶液中相对均匀，使用移液管加入0.7mL冰醋酸，搅拌十分钟，待壳聚糖溶解完全。最后精密称取海藻酸钠0.100g，边搅拌边加入，继续搅拌二十分钟至完全溶解。加入矫味剂糖精钠40mg，溶解，趁热通过放有两层纱布的布氏漏斗抽滤，得滤液、弃滤渣。
(4)将滤液置于恒温磁力搅拌器中，60℃搅拌，边搅拌边加入1.5mL丙三醇，加入0.100g口腔溃疡散，加入6滴吐温-80(约0.12mL)，继续搅拌10分钟；取出搅拌子，60℃保温静置脱泡；
(5)待脱泡完全，取25mL上述溶液，利用均浆流延成膜法铺于90mm玻璃培养皿，置于真空干燥箱，50℃、-84kPa保存5小时；小心起膜，于干燥处保存，得载药内膜；将所得载药内膜平铺于培养皿背面，量取2.5％乙基纤维素乙醇溶液4mL，利用均浆流延成膜法铺于所得载药内膜上，置于干燥通风阴凉处静置一小时，即得双层的单向释药膜剂。
(6)最后进行切割，灭菌，包装，即得总厚度为0.3～0.5mm；单片双层膜剂长宽均为1～2cm，单片双层膜剂含药物1～2mg的治疗口腔溃疡的双层膜剂。
通过现有西药口腔贴膜剂的制备工艺，将其制成双层单向释药膜剂，载药内膜有疏松小孔，有利于药物溶出析出，发挥药效；外膜不溶于水，起到保护内膜的作用，内膜可保持药物长期与溃疡面接触使疗效增强。贴膜能直接作用到溃疡患处，具有药物缓释效果，能够减轻疼痛、促进伤口愈合、缩短病程，且无副作用，粘附力强，能够牢固且持久的作用于口腔溃疡患处，患者进食和饮水时不易脱落，减少了患者进食或饮水时对口腔溃疡患处的刺激，提高患者使用舒适性。
以上所述是本发明的优选实施方式，应当指出，对于本技术领域的普通技术人员来说，在不脱离本发明所述原理的前提下，还可以做出若干改进和润饰，这些改进和润饰也应视为本发明的保护范围。
Claims (10)
1.一种治疗口腔溃疡的双层膜剂，其特征在于，为双层单向释药膜剂，包括多孔的载药内膜和防水外膜；
其中，所述载药内膜包括壳聚糖1-60份，海藻酸钠1-37份，聚乙烯醇1-7份；
所述防水外膜包括乙基纤维素、甲基丙烯酸羟乙酯、甲基丙烯酸甲酯共聚物、醋酸羟丙甲纤维素琥珀酸酯中的任意一种单独或多种组合经无水乙醇溶解后制成，浓度为1％～5％。
2.根据权利要求1所述的一种治疗口腔溃疡的双层膜剂，其特征在于，所述载药内膜还包括矫味剂0.1～1份。
3.根据权利要求1所述的一种治疗口腔溃疡的双层膜剂，其特征在于，所述双层膜剂的总厚度为0.3～0.5mm；每片双层膜剂长宽均为1～2cm，每片双层膜剂含药物1～2mg。
4.如权利要求1所述的一种治疗口腔溃疡的双层膜剂，其特征在于，所述载药内膜的药物是中成药口腔溃疡散。
5.一种治疗口腔溃疡的双层膜剂的制备方法，其特征在于，包括以下步骤：
内膜胶浆的制备：按照壳聚糖1-60份，海藻酸钠1-37份，聚乙烯醇1-7份的比例称取各组分，加水充分溶解，过滤得内膜胶浆；
载药内膜胶浆的制备：将治疗口腔溃疡的药物研细过200目筛，加入内膜胶浆，同时加入丙三醇和吐温80，搅拌充分后静置脱泡，匀浆，得含药内膜胶浆；
防水外膜胶浆的制备：无水乙醇加入高分子防水材料，配成1％～5％的浓度；所述高分子防水材料包括乙基纤维素、甲基丙烯酸羟乙酯、甲基丙烯酸甲酯共聚物、醋酸羟丙甲纤维素琥珀酸酯中的任意一种单独或多种组合；
双层膜剂的制备：按照贴膜剂的生产工艺均浆流延成膜法对载药内膜胶浆进行膜剂的铺膜，真空干燥，小心起膜，干燥后得载药内膜；将载药内膜平铺，量取防水外膜胶浆，再次利用均浆流延成膜法铺于载药内膜上，置于干燥通风阴凉处静置一小时，即得双层的单向释药膜剂，然后进行切割，灭菌，包装，即得治疗口腔溃疡的双层膜剂。
6.根据权利要求5所述的一种治疗口腔溃疡的双层膜剂的制备方法，其特征在于，载药内膜和防水外膜的重量比为(10～20)：(80～90)。
7.根据权利要求5所述的一种治疗口腔溃疡的双层膜剂的制备方法，其特征在于，真空干燥的条件为50℃、-84kPa保存5小时。
8.根据权利要求5所述的一种治疗口腔溃疡的双层膜剂的制备方法，其特征在于，防水外膜胶浆的制备中，高分子防水材料优选为乙基纤维素。
9.根据权利要求5所述的一种治疗口腔溃疡的双层膜剂的制备方法，其特征在于，内膜胶浆的制备中，还加入了矫味剂，矫味剂的加入量为0.1～1份。
10.根据权利要求9所述的一种治疗口腔溃疡的双层膜剂的制备方法，其特征在于，所述矫味剂为糖精钠。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111117249.7A CN113616627A (zh) | 2021-09-23 | 2021-09-23 | 一种治疗口腔溃疡的双层膜剂及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111117249.7A CN113616627A (zh) | 2021-09-23 | 2021-09-23 | 一种治疗口腔溃疡的双层膜剂及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113616627A true CN113616627A (zh) | 2021-11-09 |
Family
ID=78390670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111117249.7A Pending CN113616627A (zh) | 2021-09-23 | 2021-09-23 | 一种治疗口腔溃疡的双层膜剂及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113616627A (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101444527A (zh) * | 2008-12-26 | 2009-06-03 | 昆明创邦医疗器械有限公司 | 治疗口腔溃疡的药物 |
| CN105343162A (zh) * | 2015-12-01 | 2016-02-24 | 徐斌 | 独一味口腔缓释贴膜的制备方法及其检测方法 |
| CN111000830A (zh) * | 2019-09-19 | 2020-04-14 | 江苏中天药业有限公司 | 一种口腔贴膜及其制备方法 |
| CN112107592A (zh) * | 2020-09-25 | 2020-12-22 | 华熙生物科技股份有限公司 | 一种具有修复作用的口腔溃疡贴膜及其制备方法 |
-
2021
- 2021-09-23 CN CN202111117249.7A patent/CN113616627A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101444527A (zh) * | 2008-12-26 | 2009-06-03 | 昆明创邦医疗器械有限公司 | 治疗口腔溃疡的药物 |
| CN105343162A (zh) * | 2015-12-01 | 2016-02-24 | 徐斌 | 独一味口腔缓释贴膜的制备方法及其检测方法 |
| CN111000830A (zh) * | 2019-09-19 | 2020-04-14 | 江苏中天药业有限公司 | 一种口腔贴膜及其制备方法 |
| CN112107592A (zh) * | 2020-09-25 | 2020-12-22 | 华熙生物科技股份有限公司 | 一种具有修复作用的口腔溃疡贴膜及其制备方法 |
Non-Patent Citations (2)
| Title |
|---|
| 曹娜: "双孢蘑菇壳聚糖的制备及应用研究", 中国优秀硕士学位论文全文数据库 * |
| 白莉: "黄芩苷口腔缓释膜的制备及性能", 中国优秀硕士学位论文全文数据库 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103142562B (zh) | 一种治疗口腔溃疡的缓释贴膜 | |
| US9248146B2 (en) | Dissolvable adhesive films for delivery of pharmaceutical or cosmetic agents | |
| AU2005218925B2 (en) | Pharmaceutical composition for topical use in form of xerogels or films and methods for production | |
| FR2582942A1 (fr) | Rubans medicaux adhesifs pour la muqueuse buccale | |
| CN105363064B (zh) | 一种用于治疗烧伤的复方库拉索芦荟多糖凝胶抗菌敷料 | |
| JP2005002009A (ja) | フェンタニル含有口腔粘膜貼付剤 | |
| WO2018076856A1 (zh) | 一种丁香酚口腔溃疡膜及其制备方法 | |
| CN108159024A (zh) | 一种治疗口腔溃疡的缓释贴膜及其制备方法 | |
| CN110302144B (zh) | 一种缓释型双层口腔溃疡膜及其制备方法 | |
| JP2003070898A (ja) | 貼付剤とその製造方法 | |
| CN108464967A (zh) | 一种用于皮下药物可控释放的生物针及其制备方法 | |
| CN112022919A (zh) | 经皮吸收的苍艾油传递体凝胶及其制备方法 | |
| CN106063798B (zh) | 一种口腔溃疡贴膜及其制备方法 | |
| CN113713113B (zh) | 一种治疗口腔黏膜疾病的组合物及其制备方法 | |
| CN113616627A (zh) | 一种治疗口腔溃疡的双层膜剂及其制备方法 | |
| CN110090198B (zh) | 一种具有生物粘附性的缓释型口腔溃疡凝胶及其制备方法 | |
| CN105079860B (zh) | 一种具有抑菌促进药物透皮吸收的透气保湿敷料以及制备方法 | |
| CN111000794A (zh) | 一种白及多糖/生物玻璃温敏凝胶剂及其制备方法和应用 | |
| CN116056738A (zh) | 粘膜穿孔 | |
| CN1686149A (zh) | 治疗口腔溃疡创面的新型药膜及其制备方法 | |
| CN111939142A (zh) | 一种用于口腔溃疡的膜片及其制备方法 | |
| CN104434992A (zh) | 一种美洲大蠊提取物生物粘附性阴道片及其制备方法 | |
| JPH0333125B2 (zh) | ||
| TW520299B (en) | Chin Su Kao pharmaceutical paster within a water soluble substrate compound and manufacture process thereof | |
| CN108324721B (zh) | 一种药物组合物及其制备方法和用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211109 |